Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative intravenous mannitol to reduce acute kidney injury after percutaneous nephrolithotomy
IRCT20200110046073N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of Bronchitol in acute kidney failure (AKF) and nephrolithiasis, sponsored by Iran University of Medical Sciences. Primary endpoint: Incidence of acute kidney injury. Started Mar 2020; status: completed.
02
Drugs
Bronchitol
03
Conditions
acute kidney failure (AKF)nephrolithiasis
Beyond the preview
Go deeper on IRCT20200110046073N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200110046073N1.